Abstract: The present invention relates to a Lactuca sativa seed designated 79-33 RZ, which when grown into a plant exhibits a combination of traits including resistance against downy mildew (Bremia lactucae) races B1:1 to B1:28, CA-I, CA-IIA, CA-IIB, CA-III, CA-IV, CA-V, CA-VI, CA-VII, CA-VIII and strain FR10.021, resistance against lettuce mosaic virus (LMV), resistance against currant-lettuce aphid (Nasonovia ribisnigri) biotype Nr:0 as well as medium to dark green colored mature leafs with a flat or almost flat apical margin. The present invention also relates to a Lactuca sativa plant produced by growing the 79-33 RZ seed. The invention further relates to methods for producing the lettuce cultivar, represented by lettuce variety 79-33 RZ.

Abstract: Modified bacterial surface layer (S-layer) proteins are disclosed where the modification is the insertion, at an internal location, of a heterologous polypeptide, or polypeptide of interest. The polypeptide is a binding or target protein, such as an antigen or antibody, or part thereof, in particular a bacterial antigen (e.g. from Clostridium tetani such as TTFC). The modified surface layer protein can then be expressed on the surface of the bacterial cell and used in a vaccine. Also disclosed are bacteria which have been modified to express a heterologous surface layer protein, but which do not as a wild-type possess an S-layer (such as L. casei), and modified bacteria which express only a modified surface layer protein (and not the wild-type S-layer protein). The wild type S-layer is completely replaced with the modified version where the polynucleotide encoding the modified version is integrated into the bacterial genome.

Abstract: The present invention relates to a lettuce cultivar having resistance to downy mildew (Bremia lactucae) and which has an extraordinary high number of green, round-shaped leaves. The invention further relates to methods for producing the lettuce cultivar, represented by lettuce variety 79-22 RZ, referred to as Socrates, representative seed having been deposited under NCIMB Accession No. 41325.

Abstract: Modified bacterial surface layer (S-layer) proteins are disclosed where the modification is the insertion, at an internal location, of a heterologous polypeptide, or polypeptide of interest. The polypeptide is a binding or target protein, such as an antigen or antibody, or part thereof, in particular a bacterial antigen (e.g. from Clostridium tetani such as TTFC). The modified surface layer protein can then be expressed on the surface of the bacterial cell and used in a vaccine. Also disclosed are bacteria which have been modified to express a heterologous surface layer protein, but which do not as a wild-type possess an S-layer (such as L. casei), and modified bacteria which express only a modified surface layer protein (and not the wild-type S-layer protein). The wild type S-layer is completely replaced with the modified version where the polynucleotide encoding the modified version is integrated into the bacterial genome.